Understanding Patients' Awareness, Perspectives, and Approaches to Managing Dry Eye Disease
-
By
-
Chongyan Zhu
-
Yajie Zhou
-
Hongwei Zhou
-
December 29, 2025
Clinical Scorecard: Understanding Patients' Awareness, Perspectives, and Approaches to Managing Dry Eye Disease
At a Glance
| Category | Detail |
| Condition | Dry Eye Disease (DED) |
| Key Mechanisms | Characterized by ocular discomfort, visual disturbances, and tear film instability. |
| Target Population | Patients aged 18 years and older diagnosed with dry eye disease. |
| Care Setting | Outpatient settings, particularly in ophthalmology. |
Key Highlights
- Global prevalence of DED is approximately 11.59%; in China, it is 13.55%.
- High prevalence of symptomatic DED among Chinese high school students at 70.5%.
- Patients' awareness of DED symptoms is crucial for effective disease management.
- Adherence to treatments like artificial tears and anti-inflammatory medications improves prognosis.
- Knowledge, attitudes, and practices (KAP) study is essential for understanding patient responses.
Guideline-Based Recommendations
Diagnosis
- Diagnosis based on symptoms and objective examinations including TBUT, Schirmer I test, and fluorescein staining.
Management
- Utilization of artificial tears and anti-inflammatory medications based on disease severity.
Monitoring & Follow-up
- Regular follow-up visits to enhance treatment adherence and patient confidence.
Risks
- Increased psychological distress due to ocular discomfort and visual impairment.
Patient & Prescribing Data
Patients diagnosed with dry eye disease aged 18 and older.
Access to treatment may be influenced by medical insurance coverage.
Clinical Best Practices
- Implement educational interventions to improve patient knowledge about DED.
- Encourage proactive treatment approaches and adherence to prescribed therapies.
- Conduct regular assessments of patient attitudes and practices regarding DED management.
Related Resources & Content